Beauty Health Q4 2021 Earnings Report
Key Takeaways
The Beauty Health Company reported strong Q4 2021 results with net sales increasing 105.6% compared to Q4 2020, driven by growth in the U.S., EMEA, and APAC regions. The company exceeded its guidance for the quarter and full year, navigating macro challenges and COVID-19 impacts.
Net sales increased 105.6% compared to Q4 2020, reaching $77.9 million.
Delivery Systems net sales increased to $42.7 million, with over 1,800 systems sold during the quarter.
Consumables net sales increased to $35.2 million compared to the same period last year.
Adjusted EBITDA increased to $8.5 million compared to $3.6 million in Q4 2020.
Beauty Health
Beauty Health
Beauty Health Revenue by Segment
Beauty Health Revenue by Geographic Location
Forward Guidance
BeautyHealth is providing a fiscal 2022 net sales guidance range of $320.0 million to $330.0 million and adjusted EBITDA of approximately $50.0 million.
Positive Outlook
- Momentum in health and wellness
- Management's confidence in the business as the Company executes against its growth plan
- Launch in the first half of 2022 of Syndeo, the next generation HydraFacial Delivery System
- Wi-Fi-enabled radio frequency identification that will allow us to build a connected platform
- Better understand consumer and provider behavior
Challenges Ahead
- No material deterioration in general market conditions or other factors related to COVID-19 trends
- Potential risk for further market closures or other restrictive measures from existing or new COVID-19 strains
- Uneven global rollout and adoption of vaccines
- Inflationary headwinds related to higher raw material, shipping and labor costs
- Assumes a largely reopened global market, which would be negatively impacted if closures or other restrictive measures persist or are reimplemented
Revenue & Expenses
Visualization of income flow from segment revenue to net income